POST Online Media Lite Edition



 

Selcia adds Simon Saxby to the board

Staff writer |
Ongar, United Kingdom - Selcia Limited, a provider of services for medical companies, announced the appointment of Simon Saxby as a non-executive director.


Mr. Saxby is currently Vice-President Biologics of RecipharmCobra Biologics, a Swedish contract development and manufacturing company and has worldwide responsibility for the manufacturing of biologics.

Mr. Saxby has more than 25 years experience in the biotechnology industry, including several CEO positions, most recently at Cobra Biomanufacturing plc and Alpha Biologics.

 LATEST MOVES FROM United Kingdom 

Ascential appoints Paul Harrison as COO
Petropavlovsk appoints Maksim Meshcheriakov as interim CEO
Helios Towers appoints Sally Ashford as director
Syncona appoints Kemal Malik as director
Petropavlovsk appoints two nonexecutive directors